Sinusitis which is the inflammation of the Sinuses is treated with Varmam therapy(External) and Uthamathali Girutham (Internal medicine)

PHASE II NON RANDOMIZED COMPARATIVE OPEN CLINICAL EVALUATION OF VARMAM AND UTHAMATHALI GIRUTHAM (INTERNAL) FOR THE MANAGEMENT OF PEENISAM (SINUSITIS) IN PATIENTS ATTENDING VARMAM DEPARTMENT AT ARIGNAR ANNA GOVERNMENT HOSPITAL FOR INDIAN SYSTEM OF MEDICINE - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/070431

Enrollment

Registered

2024-07-10

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J018- Other acute sinusitis

Interventions

Intervention1: UTHAMATHALI GIRUTHAM (INTERNAL): UTHAMATHALI GIRUTHAM 4ML BD AFTER FOOD FOR 40 DAYS. Intervention2: VARMAM THERAPY (EXTERNAL): VARMAM THERAPY WEEKLY TWICE FOR 40 DAYS. Control Interven

Eligibility

Inclusion criteria

Inclusion criteria: Purulent nasal discharge, Nasal congestion, Facial congestion, Facial pain, Hyposmia or anosmia, Fever, Headache, Ear pain, Halitosis, Dental pain, Cough, Fatigue

Exclusion criteria

Exclusion criteria: Known case of Cancer, Vasomotor rhinitis, Ophthalmic headache, Dental infection, Fungal sinusitis, Migraine, Otitis media, COPD, Hyperlipidemia, Pregnant women and lactating mother.

Design outcomes

Primary

Measure	Time frame
Measured by Sino Nasal Outcome Test (SNOT 22) and reduction of clinical symptomsTimepoint: Measured by reduction of clinical symptoms after management for 40 days	—

Secondary

Measure	Time frame
Comparing clinical symptoms before and after treatmentTimepoint: 40 days	—

Countries

India

Contacts

Public ContactDR T R SIDDIQUE ALI

GOVERNMENT SIDDHA MEDICAL COLLEGE , CHENNAI

tkrsiddique@gmail.com9962019900

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026